Detalles de la búsqueda
1.
Efficacy and safety of adapalene gel as a reactive treatment for cetuximab-induced skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck: A historical cohort comparison study.
J Oncol Pharm Pract
; 30(2): 295-303, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37098185
2.
Potential efficacy of local therapy for progressive lesions after nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Int J Clin Oncol
; 28(8): 1023-1032, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37344738
3.
Biweekly administration of cetuximab in Japanese patients with recurrent or metastatic head and neck cancer.
Int J Clin Oncol
; 27(11): 1669-1674, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35943644
4.
A phase I, single-center, open-label study of RM-1929 photoimmunotherapy in Japanese patients with recurrent head and neck squamous cell carcinoma.
Int J Clin Oncol
; 26(10): 1812-1821, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34165660
5.
A Phase II study of the safety and efficacy of lenvatinib in patients with advanced thyroid cancer.
Future Oncol
; 15(7): 717-726, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30638399
6.
Induction TPF chemotherapy followed by CRT with fractionated administration of cisplatin in patients with unresectable locally advanced head and neck cancer.
Int J Clin Oncol
; 24(7): 789-797, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30796560
7.
Pharmacokinetics of initial full and subsequent reduced doses of S-1 in patients with locally advanced head and neck cancer-effect of renal insufficiency.
Jpn J Clin Oncol
; 47(5): 407-412, 2017 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28159957
8.
Gemcitabine monotherapy in patients with heavily treated nasopharyngeal cancer: a case series.
Int J Clin Oncol
; 22(6): 1009-1014, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28616753
9.
Regulatory T cells: A target in anticancer immunotherapy.
Nihon Rinsho
; 75(2): 181-187, 2017 02.
Artículo
en Japonés
| MEDLINE | ID: mdl-30562850
10.
Impact of prophylactic percutaneous endoscopic gastrostomy tube placement on treatment tolerance in head and neck cancer patients treated with cetuximab plus radiation.
Jpn J Clin Oncol
; 46(9): 825-31, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27317736
11.
Combined salivary duct carcinoma and squamous cell carcinoma suspected of carcinoma ex pleomorphic adenoma.
Pathol Int
; 66(8): 460-5, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27435055
12.
[Evaluation of aprepitant as a prophylactic antiemetic in the Cisplatin split regimen combined with radiation for patients with head and neck cancer].
Gan To Kagaku Ryoho
; 41(9): 1103-6, 2014 Sep.
Artículo
en Japonés
| MEDLINE | ID: mdl-25248892
13.
Long-term outcomes of patients with oral cavity cancer receiving postoperative radiotherapy after salvage neck dissection for cervical lymph node recurrence.
Head Neck
; 46(3): 541-551, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38108511
14.
Sema6D forward signaling impairs T cell activation and proliferation in head and neck cancer.
JCI Insight
; 9(3)2024 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38329122
15.
[I. Genomic Medicine in Thyroid Cancer].
Gan To Kagaku Ryoho
; 45(12): 1711-1715, 2018 Dec.
Artículo
en Japonés
| MEDLINE | ID: mdl-30587725
16.
Planned drug holidays during treatment with lenvatinib for radioiodine-refractory differentiated thyroid cancer: a retrospective study.
Front Oncol
; 13: 1139659, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37886165
17.
Impact of lenvatinib-induced proteinuria and renal dysfunction in patients with thyroid cancer.
Front Oncol
; 13: 1154771, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36998435
18.
Subsequent chemotherapy with paclitaxel plus cetuximab-based chemotherapy following immune checkpoint inhibitor in recurrent or metastatic squamous cell carcinoma of the head and neck.
Front Oncol
; 13: 1221352, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38074688
19.
Proton pump inhibitors and antibiotics adversely effect the efficacy of nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Eur J Cancer
; 184: 30-38, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36898232
20.
A pharmacist-led opioid de-escalation program after completion of chemoradiotherapy in locally advanced head and neck cancer.
Front Oncol
; 13: 1145323, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37781181